Monthly Archives: May 2020

The exercised warrants include all warrants that have been issued to investors in the Company’s public financings to date and represent approximately 70% of the Company’s overall outstanding warrants.

Austin startup a ripe M&A target for big pharma, one expert says

New license agreement expands Genprex’s oncology franchise

Company provides updates on recent regulatory, clinical, operational, and business developments